PROVIDENCE — The Rhode Island Department of Health (RIDOH) is announcing that Rhode Island is pausing administration of Johnson & Johnson vaccine as federal partners continue gathering more information.
“As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare,” the FDA reported on its feed.
No Johnson & Johnson appointments had been scheduled for release today. RIDOH is directing vaccinators that had made Johnson & Johnson vaccination appointments to not administer those doses. Additional information will be shared shortly regarding people who had already made appointments for Johnson & Johnson vaccine, according to the RI Health Department.
No information reported to RIDOH has indicated that Johnson & Johnson vaccine represents a health or safety concern. However, RIDOH is taking this step in alignment with federal partners, the RIDOH said in a statement this morning.